News for Moderna, Inc. (M1RN34.SA)

Moderna's short interest surged to 14.58% in March, signaling investor caution. Analysts forecast an average price target of $50.96, offering significan

Summary Moderna Inc (MRNA), a pioneer in mRNA medicine, has announced it will host a live conference call and webcast on May 1, 2025, at 8:00 a.m. ET to discuss

CAMBRIDGE, MA / ACCESS Newswire / April 10, 2025 / Moderna, Inc. (NASDAQ:MRNA), today announced that it will host a live conference call and webcast at 8:00 a.m

Moderna (MRNA) will announce its Q1 2025 financial results on May 1, 2025. A live webcast and conference call will take place at 8:00 a.m. ET. The webcast

As per Barclays, the US administration announced numerous executive orders with reforms associated with world trade, immigration, and global geopolitics, resulting in elevated levels of uncertainty and...

CAMBRIDGE, MA / ACCESS Newswire / April 7, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present research across multiple infectious

We recently published a list of Jim Cramer Says Wait A Little & Discusses These 11 Stocks. In this article, we are going to take a look at where Moderna, Inc.

Key Insights: FDA leadership changes stir uncertainty in the vaccine sector. Moderna's stock sees a 9% decline amid increased regulatory scrutiny. Ana

The stock market faced a challenging day as risk sentiment remained under pressure on Wall Street. The S&P 500 experienced a volatile session, hitting its lowest point in over six months before recovering some losses. The S&P ended the day 0.5% higher at 5,611.85. Despite this, the index is on track for its worst month since September 2022, with a 7% decline in March.

We recently published a list of Jim Cramer Discussed These 9 Stocks Recently. In this article, we are going to take a look at where Moderna, Inc. (NASDAQ:MRNA) stands against other stocks that Jim Cramer discussed. On Wednesday, Jim Cramer, the host of Mad Money, took a closer look at the state of the market […]

We recently published a list of Did Jim Cramer Nail or Miss These 14 Stocks? In this article, we are going to take a look at where Moderna, Inc.

The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.

Moderna (MRNA) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

Moderna, Inc.'s stock soars 16% amid patent win over Pfizer/BioNTech, while legal battles highlight mRNA challenges. Click for my MRNA update.

Moderna, Inc. (NASDAQ:MRNA) TD Cowen 45th Annual Health Care Conference March 5, 2025 9:10 AM ETCorporate ParticipantsStephen Hoge - PresidentConference...

BASEL, Switzerland and VANCOUVER, B.C. and WARMINSTER, Pa., March 03, 2025 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company with

**media[555746]**

**media[555742]**

On February 28, 2025, Moderna Inc (MRNA) announced that the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization